Ligand Pharmaceuticals Statistics
Total Valuation
LGND has a market cap or net worth of $2.21 billion. The enterprise value is $1.90 billion.
| Market Cap | 2.21B |
| Enterprise Value | 1.90B |
Important Dates
The last earnings date was Thursday, November 7, 2024, before market open.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
LGND has 18.90 million shares outstanding. The number of shares has increased by 5.70% in one year.
| Current Share Class | 18.90M |
| Shares Outstanding | 18.90M |
| Shares Change (YoY) | +5.70% |
| Shares Change (QoQ) | +2.17% |
| Owned by Insiders (%) | 1.95% |
| Owned by Institutions (%) | 99.64% |
| Float | 18.52M |
Valuation Ratios
The trailing PE ratio is 47.42 and the forward PE ratio is 33.24. LGND's PEG ratio is 2.11.
| PE Ratio | 47.42 |
| Forward PE | 33.24 |
| PS Ratio | 13.11 |
| Forward PS | 14.83 |
| PB Ratio | 2.49 |
| P/TBV Ratio | 4.67 |
| P/FCF Ratio | 28.68 |
| P/OCF Ratio | 28.11 |
| PEG Ratio | 2.11 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 36.02, with an EV/FCF ratio of 25.24.
| EV / Earnings | 41.90 |
| EV / Sales | 12.44 |
| EV / EBITDA | 36.02 |
| EV / EBIT | 105.46 |
| EV / FCF | 25.24 |
Financial Position
The company has a current ratio of 12.49, with a Debt / Equity ratio of 0.01.
| Current Ratio | 12.49 |
| Quick Ratio | 10.83 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.13 |
| Debt / FCF | 0.10 |
| Interest Coverage | 7.87 |
Financial Efficiency
Return on equity (ROE) is 6.00% and return on invested capital (ROIC) is 1.48%.
| Return on Equity (ROE) | 6.00% |
| Return on Assets (ROA) | 1.30% |
| Return on Capital (ROIC) | 1.48% |
| Revenue Per Employee | $2.63M |
| Profits Per Employee | $780,069 |
| Employee Count | 58 |
| Asset Turnover | 0.18 |
| Inventory Turnover | 1.54 |
Taxes
In the past 12 months, LGND has paid $13.57 million in taxes.
| Income Tax | 13.57M |
| Effective Tax Rate | 23.07% |
Stock Price Statistics
The stock price has increased by +96.17% in the last 52 weeks. The beta is 0.90, so LGND's price volatility has been lower than the market average.
| Beta (5Y) | 0.90 |
| 52-Week Price Change | +96.17% |
| 50-Day Moving Average | 107.95 |
| 200-Day Moving Average | 91.13 |
| Relative Strength Index (RSI) | 51.92 |
| Average Volume (20 Days) | 141,309 |
Short Selling Information
The latest short interest is 918,627, so 4.86% of the outstanding shares have been sold short.
| Short Interest | 918,627 |
| Short Previous Month | 1.00M |
| Short % of Shares Out | 4.86% |
| Short % of Float | 4.96% |
| Short Ratio (days to cover) | 10.31 |
Income Statement
In the last 12 months, LGND had revenue of $152.42 million and earned $45.24 million in profits. Earnings per share was $2.47.
| Revenue | 152.42M |
| Gross Profit | 120.06M |
| Operating Income | 17.98M |
| Pretax Income | 53.01M |
| Net Income | 45.24M |
| EBITDA | 52.63M |
| EBIT | 17.98M |
| Earnings Per Share (EPS) | $2.47 |
Balance Sheet
The company has $219.64 million in cash and $7.36 million in debt, giving a net cash position of $212.29 million or $11.23 per share.
| Cash & Cash Equivalents | 219.64M |
| Total Debt | 7.36M |
| Net Cash | 212.29M |
| Net Cash Per Share | $11.23 |
| Equity (Book Value) | 841.18M |
| Book Value Per Share | 44.84 |
| Working Capital | 284.62M |
Cash Flow
In the last 12 months, operating cash flow was $76.64 million and capital expenditures -$1.53 million, giving a free cash flow of $75.12 million.
| Operating Cash Flow | 76.64M |
| Capital Expenditures | -1.53M |
| Free Cash Flow | 75.12M |
| FCF Per Share | $3.98 |
Margins
Gross margin is 78.77%, with operating and profit margins of 11.79% and 29.68%.
| Gross Margin | 78.77% |
| Operating Margin | 11.79% |
| Pretax Margin | 38.59% |
| Profit Margin | 29.68% |
| EBITDA Margin | 34.53% |
| EBIT Margin | 11.79% |
| FCF Margin | -2.83% |
Dividends & Yields
LGND does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.70% |
| Shareholder Yield | -5.70% |
| Earnings Yield | 2.10% |
| FCF Yield | 3.49% |
Analyst Forecast
The average price target for LGND is $144.83, which is 23.56% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $144.83 |
| Price Target Difference | 23.56% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 17.68% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 19, 2010. It was a reverse split with a ratio of 0.16666:1.
| Last Split Date | Nov 19, 2010 |
| Split Type | Reverse |
| Split Ratio | 0.16666:1 |
Scores
LGND has an Altman Z-Score of 8.72 and a Piotroski F-Score of 6.
| Altman Z-Score | 8.72 |
| Piotroski F-Score | 6 |